Angela Hirbe
48PUBLICATIONS
205CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (48)
Sort by Publication Date:
|Jan 21, 2026
Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.Hua Li, Alexander Pemov, Robert Allaway
|Jan 08, 2026
SARC031: A Phase II Trial of Selumetinib and Sirolimus for Patients with Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumors (MPNST).AeRang Kim, Karla V Ballman, Pamela L Wolters
|Sep 11, 2025
Mirdametinib, an FDA-Approved MEK1/2 inhibitor for adult and pediatric NF1-associated plexiform neurofibromas.Gorkem Oztosun, Amy Armstrong, Angela C Hirbe
|Jun 24, 2025
MTA-Cooperative PRMT5 Inhibitors Are Efficacious in MTAP-Deleted Malignant Peripheral Nerve Sheath Tumor Models.Xiaochun Zhang, Dana C Borcherding, Minjie Zhang
|May 07, 2025
Phase II Study of Pexidartinib Plus Sirolimus in Unresectable Malignant Peripheral Nerve Sheath Tumors Identifies M2 Macrophage Activation.Gulam A Manji, Liam J Stanton, Angela C Hirbe
|Mar 19, 2025
Reply to: Challenges in Assessing Response in Clinical Trials for Neurofibromatosis Type 1 Plexiform Neurofibromas.Christopher L Moertel, Angela C Hirbe, Laura J Klesse
Pageof 8
Frequent Collaborators
10 joint publications
Brian Van Tine
6 joint publications
Varun Monga
6 joint publications
Christine Pratilas
6 joint publications
Taylor Sundby
5 joint publications
Jack Shern
5 joint publications
Brigitte C Widemann
5 joint publications
Dana C Borcherding
4 joint publications
Jeffrey J Szymanski
4 joint publications
AeRang Kim
4 joint publications
Yang Lyu
